Medicare Part B Drug Payments: Impact of Price Substitutions Based on 2022 Average Sales Prices
Novitas Solutions, Inc., Reopened and Corrected Cost Report Final Settlements With Obvious Errors To Collect Overpayments Made to Medicare Providers
New Mexico Did Not Ensure Attendants Were Qualified To Provide Personal Care Services, Putting Medicaid Enrollees at Risk
Massachusetts Opioid Treatment Program Services Met Many of the Federal and State Requirements
South Carolina Did Not Always Invoice Rebates to Manufacturers for Physician-Administered Drugs Dispensed to Enrollees of Medicaid Managed-Care Organizations
Utah Generally Completed Medicaid Eligibility Actions During the Unwinding Period in Accordance With Federal and State Requirements
Kansas’s Implemented Electronic Visit Verification System Could Be Improved
Certain For-Profit Nursing Homes May Not Have Complied With Federal Requirements Regarding the Infection Preventionist Position
Illinois MMIS and E&E System Had Adequate Security Controls in Place, but Some Improvements Are Needed
Massachusetts Generally Completed Medicaid Eligibility Actions During the Unwinding Period in Accordance With Federal and State Requirements
Medicare Advantage Compliance Audit of Diagnosis Codes That MMM Healthcare, LLC, (Contract H4003) Submitted to CMS
Comparison of Average Sales Prices and Average Manufacturer Prices: Results for the First Quarter of 2024
Office of Inspector General’s Partnership With the Ohio Auditor of State: Auditor of State’s Report Ohio Department of Medicaid: The Cost of Concurrent Enrollment
Medicare Improperly Paid Hospitals an Estimated $79 Million for Enrollees Who Had Received Mechanical Ventilation
Medicare and Some Enrollees Paid Substantially More When Stelara Was Covered Under Part D Versus Part B
Opioid Treatment Programs in Washington State Did Not Fully Comply With Federal and State Requirements, Which May Have Put Medicaid Enrollees at Risk for Poor Treatment Outcomes
CDC Provided Oversight and Assistance, but Recipients Faced Challenges in Implementing a COVID-19 Vaccine Confidence Strategy
The National Institutes of Health Administered Superfund Appropriations During Fiscal Year 2023 in Accordance With Federal Requirements
Alaska Medicaid Fraud Control Unit: 2023 Inspection
West Virginia Medicaid Fraud Control Unit: 2023 Inspection